iTonic Holdings (ITOC) Fundamentals 2026 — Revenue Analysis | SniperIQ
iTonic Holdings (ITOC) is a CN-listed Healthcare company in Medical - Specialties with a market capitalization of
iTonic Holdings (ITOC) has a market capitalization of approximately
iTonic Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
iTonic Holdings runs a net profit margin of -974.7%, a gross margin of 62.6%, and an operating margin of -991.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
iTonic Holdings reported revenue of $523,031 for fiscal year 2025, with net income of -$5M and earnings per share (EPS) of -0.32. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
iTonic Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
iTonic Holdings carries a debt-to-equity ratio of 0.02x and a current ratio of 8.83x, with a market beta of 4.77. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For iTonic Holdings (ITOC) the key facts are: market cap
Get iTonic Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.